| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |